Revenue Recognition

12 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Revenue Recognition

Patient Care Segment

Revenue in our Patient Care segment is primarily derived from contracts with third party payors for the provision of O&P devices and is recognized upon the transfer of control of promised products or services to the patient at the time the patient receives the device. At, or subsequent to delivery, we issue an invoice to the third party payor, which primarily consists of commercial insurance companies, Medicare, Medicaid, the VA, or Private Pay individuals. We recognize revenue for the amounts we expect to receive from payors based on expected contractual reimbursement rates, which are net of estimated contractual discounts and implicit price concessions. These revenue amounts are further revised as claims are adjudicated, which may result in additional disallowances.

The following table disaggregates revenue from contracts with customers in our Patient Care segment for the years ended December 31, 2021, 2020, and 2019:

	For the Years Ended December 31,
(in thousands)	2021		2020		2019
Patient Care Segment
Medicare	$	296,327	$	268,226	$	289,099
Medicaid	166,411		135,134		143,438
Commercial Insurance / Managed Care (excluding Medicare and Medicaid Managed Care)	327,836		296,738		323,499
Veterans Administration	89,358		76,769		89,035
Private Pay	63,396		54,736		60,620
Total	$	943,328	$	831,603	$	905,691

The impact to revenue related to prior period performance obligations was not material for the years ended December 31, 2021, 2020, and 2019.

Products & Services Segment

Revenue in our Products & Services segment is derived from the distribution of O&P components and from therapeutic solutions which includes the leasing and sale of rehabilitation equipment and ancillary consumable supplies combined with equipment maintenance, education, and training.

The following table disaggregates revenue from contracts with customers in our Product & Services segment for the years ended December 31, 2021, 2020, and 2019:

	For the Years Ended December 31,
(in thousands)	2021		2020		2019
Products & Services Segment
Distribution services, net of intersegment revenue eliminations	$	133,636	$	124,045	$	143,400
Therapeutic solutions	43,524		45,502		48,955
Total	$	177,160	$	169,547	$	192,355